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1. Introduction 
The Human papillomavirus infection is the sexually transmitted infection most frequent in 
man and woman (Koutsky, 1997; Worda, 2005). The probability of transmission of HPV 
through sexual intercourse varies from 5 to 100% with an average of 40%. The probability of 
transmission per partner (male-female) is estimated at 60% for HPV 16 and 60% for HPV 
that causes genital warts. Detection of HPV DNA by the molecular biological methods, does 
not necessarily represent the manisfestation of a disease (Burchell et al, 2006). According to 
The World Health Organization (WHO), more than 630 million men and women (1 in every 
10 people) are infected with HPV in the world (Ferlay et al, 2004; CDC, 2007). Clinical 
manifestation is present in less than 10% and the infection is often asymptomatic and can be 
unnoticed by the patient even though a lesion is present. It is believed, that approximately 
1/3 of all women en the world have some form of clinically manifested HPV infection. Also, 
half of all the women of the world sexually active are infected with this virus (Snoeck, 2006). 
It is believed as well that after exposure to HPV, the virus infects the entire lower genital 
tract epithelium (Shepherd & Bryson, 2008). The incubation period is highly variable, 
ranging from a few days to many years (20 to 30 years or more) (Sinal & Woods, 2005) 
(Figure 1). When the infection process starts, there is a proliferation phase ranging from 
from 3 to 6 months, when many lesions many lesions appear. After the response of B and T 
cells to the infection, what follows is the containment phase that also lasts for 3 to 6 
months, when regression will occur to more than 80% of the lesions. The other 20% will 
have an active disease or recurrence after variable disease-free intervals (Franco & Steben, 
2007). The clinical manifestations are variable and are associated with systemic and local 
immune response of each individual, with different environmental factors. Dependent on 
the host immune system, the course of the infection can take one of the three following 
forms. The most frequent is the Latent Infection, where no clinical manifestation of the 
infection occurs, and it is only detected by the HPV DNA detection methods. The second 
form is the Subclinical Infection with minimal clinical manifestation, that is usually 
diagnosed by colposcopy, cytology and histology. The third form, that is the least common   
is the Clinical Infection. In this form there is an active expression of the disease, manifested 
mainly by genital warts, precancerous lesions and invasive cancer (Chow et al, 2010). The 
www.intechopen.com
Human Papillomavirus and Related Diseases  
– From Bench to Bedside – A Clinical Perspective 
 
84
different manifestations are also dependent on different types of HPV (currently more 
than 200 types) and also the host immune system (Bernard, 2005). The low-risk HPV will 
mainly produce warts (condyloma) and the high risk HPV will mainly produce an 
intraepithelial lesion (Trofatter, 1997). 
 
 
 
 
 
Fig. 1. A 75-year-old woman sexually inactive for 25 years showing a wart  on the vulva that 
appeared 6 months ago. There is also a  VAIN  3 and an urethral cancer HPV 16 induced. 
2. Clinical lesions 
Clinical lesions (only 2 to 3% of HPV infections) are mainly represented by condyloma 
acuminatum,  Bowenoid papulosis (vulvar intraepithelial neoplasia usual type) and 
Buschke-Loewenstein tumor. The presence of acuminate lesions on the cervix (Figure 2) are 
infrequent (in 6% of the women that have vulvar condyloma) and this represents an 
indication of high-risk HPV infections (20% of these infections have associated an 
intraepithelial lesion) (Scheurer et al, 2005). Genital warts are easily recognized by papillary 
epithelial proliferations, often with vascular loops inside. Lesions may be single or multiple, 
scattered or confluent (Sadjadi et al, 2003) (Figure 3 and 4). 
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Fig. 2. Condyloma acuminata in the cervix 
 
Fig. 3. Multiple condyloma acuminata on the vulva 
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Fig. 4. Detail of a condyloma  acuminatum with a characteristic  central vessel. 
Vaginal warts can be detected by careful examination in more than one third of the cases of 
women who have vulvar warts. Generally, they are usually small and multiple and can be 
hidden by the speculum. The lesions may involve the entire length of the vagina, but most 
frequentely occur in the upper and lower thirds of the vagina (Figure 5). Although vaginal 
warts are usually asymptomatic, vaginal discharging and itching can occur, and less often,  
post-coital bleeding, may be present (Row et al, 1981).  
 
Fig. 5. Multiple vaginal warts  in the upper third of the vagina 
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The verrucous lesions in the vulvar region have increased in numbers in recent years, 
affecting mainly younger women. Vulvar warts generally occur in moist areas of the skin 
and in places subjected mostly to trauma during intercourse.  
About 25% of the women with vulvar warts have these lesions in the anal and perianal 
region as well, and are not necessarily associated with the practice of anal sex (Figure 3). 
These lesions may be sessile or pedunculated, papular, hyperkeratotic or hyperpigmented. 
Vulvar manifestations depend on each individual, ranging from small lesions (Figure 6) to 
gigantic such as in the cases of a Buschke-Loewenstein tumor (Ambriz-Gonzalez et al, 2005) 
(Figure 7). Papular and hypercrhromic vulvar lesions (vulvar intraepithelial neoplasia (VIN) 
usual type) (Figure 8) represent today, a high-grade intraepithelial neoplasia (Forcier   &  
Musacchio, 2010). 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6. Small vulvar wart 
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Fig. 7. Buschke-Loewenstein tumor  in a woman of 18 years who begun  sexual activity  6 
months before with only the same partner 
 
Fig. 8. A typical example of VIN usual type with hyperchromic papules coalescing  
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Approximately 18% of women with vulvar condyloma have anal and perianal warts as well 
(Figure 9). Depending on the extent of the injuries, discomfort or bleeding may occur during 
evacuation. In these cases, the rectal examination should also be performed, since 
approximately 10% of women with anal warts, exhibit rectal lesions (Nadal et al, 1999). 
 
Fig. 9. Multiple condyloma acuminatum in the anal and perianal region 
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When evaluating male partners of women with genital disease associated with HPV, 
approximately 40 to 50% of them also have lesions. The lesions may manifest as penile 
warts, papules or papillae. The lesions appear mainly in areas of trauma, especially related 
to sexual activity (the penile shaft, preputial cavity, coronal sulcus and glans) (Figure 10). 
Urethral involvement  (Figure 11)  is more frequent in men  than women (10 to 28% of the 
men with genital warts and less than 5% of the women with genital diseases associated with 
HPV) (Buechner, 2002). 
 
Fig. 10. Genital warts  at the base of the penile 
 
Fig. 11. Condyloma in the urethra of a young man 
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3. Sub-clinical lesions  
Subclinical lesions represent 60% of the cases of external anogenital HPV and 95% of the 
cases of cervical HPV infection. The main symptoms are micropapillary, micropapular, 
spike, and keratotic lesions. The diagnosis of these lesions is accomplished primarily by 
colposcopy, cytology and histology (Forcier  &  Musacchio, 2010).  
The cytopathic effects of HPV infection, specifically koilocytotic atypia, dyskeratosis and the 
cellular multinucleation are detected in 2 to 3% of routine Pap smears (Figure 12). The 
cytological and histological patterns of HPV-induced lesions are essentially the same 
(Wright, 2006)  (Figure 13).  
 
Fig. 12. Cytopathic effects of HPV infection (koilocytotic atypia)  
 
Fig. 13. Histology of a cervical intraepithelial neoplasia with cytopathic effects of HPV 
infection (koilocytosis)  
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Cervical intraepithelial neoplasia (CIN) is the most common manifestation of HPV in the 
cervix. These lesions are manifested by colposcopy using acetic acid that produces aceto-white 
epithelium, punctation or mosaic. At the colposcopic exam, the cellular changes in the low-
grade squamous intraepithelial lesions (LSIL) are discrete (Figure 14) while in high-grade 
lesions (HSIL) are bigger (Figure 15), including an atypical vascularization. An aceto-white 
lesion outside the cervical transformation zone is highly suggestive of an HPV infection 
(Figure 16). The low-grade lesions often regress spontaneously, ranging from 25 to 60% in one 
year. The regression rate for high-grade lesions  is much smaller (Chase et al, 2008).  
 
Fig. 14. Colposcopy of a low-grade squamous intraepithelial lesion caused by the HPV 
infection (mosaiciform lesion) 
 
Fig. 15. Colposcopy of a high-grade squamous intraepithelial lesion caused by the HPV 
infection (atypical vessels) 
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Fig. 16. Aceto-white lesion outside the cervical transformation zone due to the HPV infection 
The manifestations of the HPV infection in the vagina is poor. Changes are usually aceto-
white, flat or the micropapillary lesion that are  visible after the application of acetic acid at 2 
to 5% (Figure 17) and are better visualized after applying Lugol's iodine (Figure 18). The 
punctation and mosaics caused by HPV should be differentiated mainly from the congenital 
transformation zone and may be related to a vaginal low or high-grade  intraepithelial 
neoplasia (Davis, 1993) . The natural history of  vaginal intraepithelial neoplasia (VAIN) 
based on a 3-year follow-up study of no treatment suggests a regression rate of 78%, 13% 
persistence, and 9% progression to cancer (Aho et al, 1991). 
 
Fig. 17. Colposcopy of a vaginal intraepithelial neoplasia after applying acetic acid 2% 
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Fig. 18. The visualization of a vaginal intraepithelial neoplasia with colposcopy is better 
after applying Lugol's iodine solution 
The colposcopic examination of the vulva after the application of acetic acid at 5% permits  the 
identification of the minimum changes associated with HPV, usually expressed by the aceto-
white epithelium. These changes are often multifocal and commonly involve the vaginal 
fourchette and labia minora. It is necessary, however, to have an expert colposcopist  to 
differentiate the subclinical alterations induced by HPV from inflammatory changes (Gagné, 
2008). The vulvar intraepithelial neoplasia (VIN) associated with HPV (VIN usual type) has a 
very small risk of progression to an invasive lesion. The most severe intraepithelial lesions 
(VIN differentiated type, that are not associated with HPV) tend to be multicentric and 
multifocal. These lesions may be associated with pruritus and local irritation (Heller, 2007).  
 
Fig. 19. A  hyperpigmented  and  aceto-white  lesion  of  a  vulvar  intraepithelial neoplasia 
(VIN usual type) of  the minor labia observed  by colposcopy  after applying acetic acid 5%.  
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Subclinical changes in the perianal and anal area  are much less frequent and pratically all 
are associated with an aceto-white epithelium of varying severity after the use of acetic acid 
at 5% (Chin-Hong  & Palefsky 2002)  (Figure 20). 
 
 
 
 
 
 
 
 
 
Fig. 20. Aceto-white epithelium of an anal intraepithelial neoplasia  observed by colposcopy 
after applying acetic acid 5% 
When evaluating with colposcopy (peniscopy) and acetic acid on male partners of women 
with genital disease associated with HPV, approximately 40 to 50% of them also have 
lesions associated with HPV. About 20 to 30% of partners of women with cervical 
intraepithelial neoplasia also have a penile intraepithelial neoplasia (PIN). Half of these 
lesions are subclinical. Circumcised men have a lower prevalence of subclinical disease due 
to the majority of the lesions being located on the foreskin. Penile intraepithelial neoplasias 
may also exhibit a hyperchromic (Figure 21) or reddish lesion. Rarely these lesions are 
symptomatic, but when this occurs, itching or burning is more frequent (Krebs & Schneider, 
1987). 
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Fig. 21. Penile  intraepithelial  neoplasia  observed  by  peniscopy  after applying acetic acid 
5% exhibiting hyperpigmented papules on the foreskin   
4. Latent infection 
In latent infections there are no clinical manifestation. In the general female population, the 
prevalence of the HPV infection ranges from 2 to 44%. Infection also occurs in 
approximately 8% of women who are not yet sexually  active and approximately 20% in 
women who have had sexual activity with women only. In men, the percentage of HPV 
infection can reach as high as 45%, depending on the population studied. The diagnosis of 
latent infection is performed using molecular biology methods, especially the hybrid 
capture and polymerase chain reaction (PCR) methods, due to the clinical examination, 
colposcopy, cytology and histology are normal (Chow et al, 2010). 
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